Drug Profile
MCI 116
Latest Information Update: 23 May 1995
Price :
$50
*
At a glance
- Originator Osaka University
- Class Anti-ischaemics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ischaemic heart disorders
Most Recent Events
- 23 May 1995 Discontinued-Preclinical for Ischaemic heart disorders in Japan (Unknown route)